 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: TYSABRI (natalizumab) |
|
***************************************************** |
|
#Post#: 3726-------------------------------------------------- |
|
Tysabri biosimilar for relapsing MS under FDA review |
|
By: agate Date: July 28, 2022, 12:12 am |
|
--------------------------------------------------------- |
|
A biosimilar isn't quite a bioequivalent but biosimilars of many |
|
costly drugs are being developed because they're apparently |
|
close enough to be safe--and are far less expensive. Now Tysabri |
|
may become available in the US in biosimilar form (natalizumab). |
|
From Multiple Sclerosis News Today (July 27, |
|
2022)--"Natalizumab, biosimilar of Tysabri for relapsing MS, |
|
under FDA review": |
|
https://multiplesclerosisnewstoday.com/news-posts/2022/07/27/natalizumab-relaps… |
|
#Post#: 4136-------------------------------------------------- |
|
Tyruko (Tysabri biosimilar) has FDA approval (FDA news release) |
|
By: agate Date: August 26, 2023, 7:39 pm |
|
--------------------------------------------------------- |
|
FDA news release (August 24, 2023)--"FDA Approves First |
|
Biosimilar to Treat Multiple Sclerosis": |
|
https://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimil… |
|
#Post#: 4140-------------------------------------------------- |
|
FDA approves Tyruko, natalizumab (Tysabri) biosimilar |
|
By: agate Date: August 31, 2023, 1:19 am |
|
--------------------------------------------------------- |
|
Another news story about Tyruko--from Medical News Today (August |
|
30, 2023)--"FDA Approves First Natalizumab Biosimilar for MS |
|
Treatment": |
|
https://tinyurl.com/2p8rcarh |
|
***************************************************** |
